Document Detail

Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis.
MedLine Citation:
PMID:  14767289     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Interstitial cystitis (IC) is one of the most bothersome conditions in urological practice. There are 2 subtypes, classic and nonulcer IC, with similar symptoms but different outcomes with respect to clinical course and response to treatment. Histologically there are fundamental differences between the 2 subtypes, classic IC presenting a severe abnormality of the urothelium and characteristic inflammatory cell infiltrates while inflammation is scant in nonulcer IC. Regulation of urinary nitric oxide synthase activity has been proposed to be of importance for immunological responses in IC. We present evidence of a profound difference between the 2 subtypes concerning nitric oxide production, mirroring the differences in inflammatory response in IC. MATERIALS AND METHODS: A total of 17 patients with both subtypes and active disease as well as patients with disease in remission were included in the study, all diagnosed according to National Institute for Diabetes and Digestive and Kidney Diseases criteria. Luminal nitric oxide was measured in the bladder of patients using a chemiluminescence nitric oxide analyzer. RESULTS: All patients with classic IC had high levels of NO. None of the other patients had any significant increase in NO levels in the bladder. The NO level in patients with classic IC was not related to symptoms but rather to the assignment to this specific subgroup of IC. The highest levels of NO were found in patients in the initial phase of classic IC. CONCLUSIONS: The difference in NO evaporation between classic and nonulcer IC allows for subtyping of cases meeting National Institute for Diabetes and Digestive and Kidney Diseases criteria without performing cystoscopy. The findings in the present series together with previous findings clearly demonstrate that the 2 subtypes of IC represent separate entities. This separation further emphasizes the need to subtype all cases included in all scientific matters, ensuring that the 2 subtypes are evaluated separately in clinical studies.
Y R Logadottir; Ingrid Ehren; Magnus Fall; N Peter Wiklund; Ralph Peeker; Philip M Hanno
Related Documents :
18384639 - Twenty years of experience with krzeski's cystovaginoplasty for vaginal agenesis in may...
3792169 - Lateral internal sphincterotomy in the treatment of hemorrhoids. a clinical and manomet...
18987529 - Cerebral control of bladder storage in patients with detrusor overactivity.
3954009 - Reduction of heat loss during transurethral resection of the prostate.
9775429 - Defining the role of the bladder-neck sling in the surgical treatment of urinary incont...
9329209 - The chronic anal fissure treatment by internal partial lateral sphincterotomy and follo...
22741109 - Efficacy of i-scan endoscopy in the diagnosis of gastroesophageal reflux disease with m...
20414979 - The transcrusal approach: a 10-year experience at one canadian center.
25131559 - Quadrivalent asymmetry in reciprocal translocation carriers predicts meiotic segregatio...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of urology     Volume:  171     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-02-09     Completed Date:  2004-03-30     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1148-50; discussion 50-1     Citation Subset:  AIM; IM    
Department of Urology, Sahlgrenska University Hospital, Götenborg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cystitis, Interstitial / diagnosis*,  metabolism*
Diagnosis, Differential
Middle Aged
Nitric Oxide / biosynthesis*
Urinary Bladder / metabolism*
Reg. No./Substance:
10102-43-9/Nitric Oxide
Comment In:
J Urol. 2004 Nov;172(5 Pt 1):2083; author reply 2083   [PMID:  15540795 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical fa...
Next Document:  Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen inj...